Evidence map›Paper›PMID 29875029›Full record

ArticleComparative medicine2018

Effect of Daytime Blue-enriched LED Light on the Nighttime Circadian Melatonin Inhibition of Hepatoma 7288CTC Warburg Effect and Progression.

Robert T Dauchy, Melissa A Wren-Dail, Lynell M Dupepe, Steven M Hill, Shulin Xiang, Muralidharan Anbalagan, Victoria P Belancio, Erin M Dauchy, David E Blask

Abstract read
In one paragraph

Article in Comparative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Hepatocellular Carcinoma Around the Clock.Current oncology (Toronto, Ont.) · 2026
    Review
  3. Review
  4. The circadian rhythm as therapeutic target in inflammatory bowel disease.Journal of the Canadian Association of Gastroenterology · 2025
    Article
  5. Circadian rhythm disruption and endocrine-related tumors.World journal of clinical oncology · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Circadian Rhythms, Disease and Chronotherapy.Journal of biological rhythms · 2021
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Cancer and the Circadian Clock.Cancer research · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Robert T DauchyDepartments of Structural and Cellular Biology, Tulane University School of Medicine, Tulane, Louisiana, USA. rdauchy@tulane.edu.
Melissa A Wren-DailDepartments of Structural and Cellular Biology, Tulane University School of Medicine, Tulane, Louisiana, USA.
Lynell M DupepeDepartments of Comparative Medicine, Tulane University School of Medicine, Tulane, Louisiana, USA.
Steven M HillDepartments of Structural and Cellular Biology, Tulane University School of Medicine, Tulane, Louisiana, USA.
Shulin XiangDepartments of Structural and Cellular Biology, Tulane University School of Medicine, Tulane, Louisiana, USA.
Muralidharan AnbalaganDepartments of Structural and Cellular Biology, Tulane University School of Medicine, Tulane, Louisiana, USA.
Victoria P BelancioDepartments of Structural and Cellular Biology, Tulane University School of Medicine, Tulane, Louisiana, USA.
Erin M DauchyDepartments of Structural and Cellular Biology, Tulane University School of Medicine, Tulane, Louisiana, USA.
David E BlaskDepartments of Structural and Cellular Biology, Tulane University School of Medicine, Tulane, Louisiana, USA.
Tulane University · US

Funding

Circadian Disruption by Light at Night Induces Intrinsic Tamoxifen Resistant Breast CancerR56CA193518 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI BLASK, DAVID, HILL, STEVEN M · 2015 to 2016
$527k
NCI NIH HHS R56 CA193518
6 · The paper itself

Abstract

Liver cancer is the second leading cause of cancer death worldwide. Metabolic pathways within the liver and liver cancers are highly regulated by the central circadian clock in the suprachiasmatic nuclei (SCN). Daily light and dark cycles regulate the SCN-driven pineal production of the circadian anticancer hormone melatonin and temporally coordinate circadian rhythms of metabolism and physiology in mammals. In previous studies, we demonstrated that melatonin suppresses linoleic acid metabolism and the Warburg effect (aerobic glycolysis)in human breast cancer xenografts and that blue-enriched light (465-485 nm) from light-emitting diode lighting at daytime (bLAD) amplifies nighttime circadian melatonin levels in rats by 7-fold over cool white fluorescent (CWF) lighting. Here we tested the hypothesis that daytime exposure of tissue-isolated Morris hepatoma 7288CTC-bearing male rats to bLAD amplifies the nighttime melatonin signal to enhance the inhibition of tumor growth. Compared with rats housed under a 12:12-h light:dark cycle in CWF light, rats in bLAD light evinced a 7-fold higher peak plasma melatonin level at the mid-dark phase; in addition, high melatonin levels were prolonged until 4 h into the light phase. After implantation of tissue-isolated hepatoma 7288CTC xenografts, tumor growth rates were markedly delayed, and tumor cAMP levels, LA metabolism, the Warburg effect, and growth signaling activities were decreased in rats in bLAD compared with CWF daytime lighting. These data show that the increased nighttime circadian melatonin levels due to bLAD exposure decreases hepatoma metabolic, signaling, and proliferative activities beyond what occurs after normal melatonin signaling under CWF light.

Indexed as

Disease ProgressionPhotoperiodAnimalsCarcinoma, HepatocellularCircadian RhythmGlycolysisHeterograftsLightLiver Neoplasms, ExperimentalMaleMelatoninRatsSignal TransductionMelatonin

Identifiers

PMID29875029
PMCPMC6103418
OpenAlexW2805766913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.